clinical trial · NCT07684586
A Study to Investigate the Difference In Blood Levels of Camlipixant Between Different Camlipixant Formulation Prototypes
CoughCamlipixant
brief summary
This is an open-label study being conducted in healthy adults, to learn what happens to the study medicine (camlipixant) they are receiving in a person's body over time (a pharmacokinetic \[PK\] study). The goal of the study is to understand how the body processes camlipixant, to check its safety and how well it is tolerated. Participants will receive camlipixant at different dose levels with different formulation types either on an empty stomach or after a meal.
started
Jul 2, 2026
primary completion
Aug 27, 2027
completion
Aug 27, 2027
last updated
Jul 24, 2026
official title
A Phase 1 Study to Evaluate the PK and Relative Bioavailability of Different Formulation Prototypes of Camlipixant
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol